Tag: BARC

  • TV in India may grow 10.3%, overall AdEx by 11.5% in ’17: IPG Magna

    MUMBAI: India is recovering from the aftereffects of demonetisation, and the currency deficit faced during this period has helped the country leap frog towards a lesser cash economy.

    The country is set to move towards a uniform tax regime with Goods & Services Tax (GST), effective July 2017, while this fuels growth it is likely to create a fleeting disruption in the short term when the industry realigns and adapts to the new tax structure. GDP in real terms is estimated to grow +7.2% in 2017 compared to +6.8% in 2016 according to International Monetary Fund (IMF). Within the next decade India will gallop to become one of the largest consumer markets in the world according. Rising affluence, ease of doing business, urbanization and enabling infrastructure will contribute to this status.

    Advertising revenue which is accounts for 0.38% of GDP (gross domestic product) is likely to grow CAGR of +12.6% to touch INR 992 bn by 2021. Within Advertising, offline is estimated to grow at a CAGR of +9.7%, while digital will grow at +25.5% CAGR in the next five years. Mobile is projected to overtake desktop by 2020. Television will still be the largest media in 2021 with a market share of 39%.

    In 2017, Adex is estimated to grow +11.5% to touch INR 611bn, predicts Magna, the intelligence, investment and innovation strategies agency of IPG Mediabrands. Ad spends will be driven by sectors like social, fin-tech, and payment banks, telecom service, content distribution platforms etc., in addition to FMCG, Auto and Ecommerce.

    Television, the foundation of advertising spends, continues to dominate the industry with its market share of 41% and will grow+10.3%.  With BARC release of rural audience data, new revenue stream in the form of FTA channels have gained significance. Quality localized content and HD experience will help regional TV to keep their audiences hooked. Sporting leagues outside of Cricket is finding way to generate mass involvement and Television will play a larger role. Star Sports Tamil demonstrating tangible results will increase fandom for local/state level formats.

    Print in India has been successful in guarding its revenues well with revenue expected to grow by +5.7% and India is one of the large markets where circulation is still growing thanks to rising literacy. The second biggest category with 36% share despite growing is losing its share to Digital year-on-year. Traditional sectors like auto, telecom and education will contribute to ad spend growth.  After a gap of 3 years, the category will invigorate with the release of new IRS and help publishers realize merit based value. Audit Bureau of Circulation (ABC) measuring digital consumption will lend authority and help in monetization. We expect the ad spends to grow beyond the estimated +5.7% in 2017 thanks to government’s focused campaign to popularize their marquee initiatives.

    Digital will grow +28%, and, within digital, mobile is driving spends with a growth rate of +65.7%. The launch of 4G triggered low price data products there by increase in usage. With improved speed Video, native and customized content has tremendous potential to grow.  BARC putting out a road map on digital panel takes India one step closer to a robust measurement not only for digital but also to showcase capabilities in incremental metrics. With expanding content library, OTT viewing is no more restricted to national languages. Aggressive push by Amazon and Netflix to address the original content gap will attract larger base of audience. With mobile increasingly being the choice of access, traffic will be higher than desktop resulting in advertising propelled by mobile which is estimated to expand at CAGR of 48%. E-commerce, Telecom, Auto, BFSI, Durables are large contributors to the revenue.

    Radio reach with around 150 new frequencies sold during phase III is set to deepen further and will help generate incremental revenue. We estimate radio to grow +13% and continue to grow at CAGR of 13.8% in the next 5 years. Currently the measurement is limited to 4 cities, widening this will help radio increase its share from the current 4%

    OOH will grow +12% in 2017. Technology integration will increase effectiveness and helps DOOH to drive ad spends. Urbanization in the form of new Metro lines and smart cities, modernization of Indian Railways and their new advertising policy etc., will provide opportunities for a planned development of quality assets and also push the industry to innovate and move beyond billboards. Regional cinema is pushing boundaries to outdo Bollywood cinema which augurs well for the industry.

    Table 1 – Media owner revenue by category in INR Cr Net

    public://F1_12.jpg

    Table 2 – Traditional Vs Digital Adex growth rate

    public://F2_5.jpg

    Table 3 – Mobile gaining shares over desktop

    public://F3_0.jpg

     

  • ICC Champions Trophy makes its presence felt Across Genres

    BENGALURU: Indians are cricket crazy – a cliché if ever there was one – but a cliché that makes itself evident every time there is a major cricketing event. And an event such as the ICC Champions Trophy 2017 is sure to attract eyeballs galore.

    Broadcast Audience Research Council of India (BARC) data for week 23 of 2017 (Saturday, 3 June 2017 to Friday, 9 June 2017) – List of Top 10 Channels Across Genre: All India (U+R): 2+ Individuals revels the entry of three channels that air the Champions Trophy into its fold. Star Sports 1 Hindi at second place, DD National at ninth place and Star Sports 1 at tenth place entered this list, while Sony Max which had aired the T20 IPL season 10 that ended in week 21, exited the top 10 channels across genre list in week 23.

    That the Champions Trophy is responsible for the high ratings of non-sports channel such as DD National is substantiated by the fact that two Champions Trophy matches – the one between India and arch rivals Pakistan and the one between India and its island neighbour Sri Lanka were amongst the top 5 most watched programmes for the Hindi GECand Hindi GEC – Rural and HindiGEC – Urbangenres in week 23 according to BARC data.Even in the case of the Hindi GEC – Urban genre, the Indo-Pak on DD-National match was the fifth most watched programme in week 23 of 2017.

    Besides the channels that aired the Champions Trophy, one Tamil and Telugu GEC each and five Hindi GEC channels were also present in the list of top 10 channels across genres list for week 23.

    As has been the norm, the Sun TV Network’s Tamil flagshipGEC Sun TV headed the list with weekly impressions of 1055.419 million, followed by Star Sports 1 Hindi with weekly impressions 777.806 million. Also from the Star India stable- its Hindi GEC flagship channel Star Plus stood third with 660.801 million impressions followed by Sony Pictures Network India (SPN) Sony Pal with 543.309 million weekly impressions.

    Network 18’s Hindi GEC Rishtey was ranked fifth across genres in week 23 with weekly impressions of 532.853 million followed by the Zee Entertainment Enterprises Limited (Zeel) flagship Hindi GEC Zee TV with 522.673 million weekly impressions at sixth rank. Also from the Zeel stable was Hindi GEC Zee Anmol with weekly impressions of 490.769 million at seventh place followed by The Sun TV Networks Teluguflagship channel Gemini TV with 478.453 million impressions at eighth place.

    DD National with 466.696 million weekly impressions stood ninth followed by Star Sports 1 with 462.214 million weekly impressions.

  • Times Now-Republic TV on-air ratings spat continues as each claims top spot in week 23

    BENGALURU: Last week on Thursday, just post 11 am, the newborn Republic TV and the grand old lady of the English news business Times Now, starting flashing BARC data, each claiming the number one spot in viewership. The channels have continued this on-air spat once again. Republic TV says that it has done it once again, if one were to go by the Indian ratings monitor Broadcast Audience Research Council of India (BARC) numbers flashed by it on the channel for week 23 (Saturday, 3 June 2017 to Friday, 10 June 2017).

    Republic TV claims that it has been number one across all segments in week 23. It claims 147 per cent greater viewership than Times Now across all segments across India and 247 per cent greater viewership than Times Now at super primetime.

    In the meantime, Times Now has been flashing on its channel that it is the number one in the English news genre with a relative viewership of 42 per cent while putting Republic TV at second place with a relative viewership of 31 per cent. Times Now puts CNN News 18 9 per cent India Today TV’s relative share at 7 per cent, and NDTV 24×7 at 5 per cent each.

    Republic TV shared viewership details of the other peers in the English News genre: Times Now-28.8 per cent; CNN News 18-12 per cent; India Today News-11 per cent; NDTV-19 per cent; News X-2.5 per cent.

    “The viewership debate is over, we are number 1. It is now one month since we have been in operation and we have now become undisputed leaders in this genre. The game has just begun and we are now absolutely unstoppable. We will take the game to the next level,” declared Republic TV editor-in-chief Arnab Goswami last week, during a live telecom with Republic TV anchor Hariharan aired on his channel, just after 11:15AM.

    It may be recalled that in a coordinated move, English News channels had pulled out of BARC on 18 May, only to return to the BARC fold on from midnight of 26 May. English News channels backed by the News Broadcast Association had stripped their signals of BARC audio watermarks. The NBA had requested BARC not to publish Republic TV’s ratings, alleging that the channel has resorted to rampant multiple LCN placements on cable TV networks across the country.

  • IPL: Oppo, Vivo, Jio & Amazon ads ruled

    BENGALURU: Mobile handsets and mobile services, including data services ruled the air on the channels that broadcast the tenth season of the cricket T20 Indian Premier League (IPL 10 or IPL 2017) according to Broadcast Audience Research Council of India (BARC) for the weeks during which live IPL 10 matches were aired. The number of insertions by the top 10 advertisers and brands during IPL10 were 22.9 percent and 10.4 percent more respectively than the spots booked by the top10 advertisers and brands during IPL 9.

    The excitement built up for the event saw IPL 10 recording the highest viewership for the season in week 15 till date for all the Sony Pictures Network (SPN) channels that broadcast the event  – the two Hindi Movie channels – Sony Max and two Sports channel’s Sony Six.(English) and Sony ESPN (commentary in Tamil, Telugu, Bengali, Hindi).These channels have been collectively termed as IPL10 channels in this paper.

    IPL 10 commenced on Wednesday, 5 April 2017. The mega T20 cricket bonanza played by 8 teams comprising of over 200 players including 72 international players concluded with the finals on Sunday, 21 May 2017, after 60 matches  (59 played, one washed out) spread over 47 days.

    BARC week 14 commenced on Saturday, 1 April 2017 and ended on Friday, 7 April 2017. Three days of play with three matches played happened in week 14. The event concluded in the beginning of week 21 – only one match –the final, was played during that week. Ten matches were played during each of BARC weeks15, 16 and 18. Nine matches were played in weeks 17 and 19 and seven planned for week 20, with just one in week 21 as mentioned above.

    A total of 21,964 insertions were made by the top 10 advertisers during IPL 10 on the channels that aired the event. Last year the top advertisers had 17,870 spots on these channels.55.6 percent (12,223 insertions) of these spots were booked by two Mobile phone suppliers and two mobile services each – Oppo India (Oppo) was the largest advertiser on the SPN channels during IPL10 with 4,285 insertions followed by Vivo Mobile India Pvt Ltd with3,767 insertions. Mobile and data services provider Reliance Jio Infocomm was the third biggest advertiser during IPL 10 on IPL channels with 2,504 insertions. Vodafone Essar Limited was ranked the seventh biggest advertiser with 1,667 insertions. Please refer to the table below for the 10 largest advertisers on IPL broadcasting channels during IPL 10 weeks.

    public://11111111111111_0.jpg

    Oppo split the insertions mainly with two variants of it mobile phone model – Oppo F3 plus, which was the most advertised brand during IPL 10 on the channels that aired IPL 10 with 2,909 insertions and ads that combined both Oppo F3 and F3 plus with 1,376 insertions. The second most advertised brand during IPL 10 on IPL channels was Jio Digital Life with 2,317 insertions.  Like Oppo, Vivo split its spots with both variants of it mobile phone – the Vivo V5 and the Vivo V5 plus.Another mobile brand from Micromax – the Micromax Canvas 6 series was the eighth most advertised brand during IPL 10 on IPL channels with 916 insertions. Please refer to the table below for the most advertised brands during IPL 10 and IPL 9.

    public://222222222222222.jpg

     

  • Two most watched prime time Hindi GEC soaps in 2017

    BENGALURU: Two of the Ekta Kapoor headed BalajiTelefims Limited soaps on competing networks and channels were the most watched primetime programmes during the first 22 weeks of calendar year 2017. One is a supernatural drama series and the other a family soap. This paper is based on the analysis of Broadcast Audience Research Council of India (BARC) ratings data from the weekly list of top five programmes in the Hindi GEC (HSM (U+R) : NCCS All : Prime Time (1800 – 2330 hrs) : 2+ Individuals); Hindi GEC – Rural (HSM (Rural) : NCCS All : Prime Time (1800 – 2330 hrs) : 2+ Individuals); and the Hindi GEC – Urban (HSM (Urban) : NCCS All : Prime Time (1800 – 2330 hrs) : 2+ Individuals) spaces.

    Naagin 2, on Network 18’s flagship Hindi GEC Colors, has been present in BARC’s weekly list of top 5 five Hindi GEC programmes during all the first 22 weeks of 2017, as was KumkumBhagya on Zee Entertainment Enterprises Limited (Zeel) flagship Hindi GEC Zee TV.  Both the programmes were continuations from 2016.

    Naagin 2 started off at the top of the charts right from the first week of 2017 as far as the Hindi GEC (Urban+Rural) genre is concerned.Naagin 2 was ranked first for 13 of the first 22 weeks of 2017, second for 8 of the first 22 weeks of 2017 and third for one week of 2017. However, with the onset of the tenth edition of the Indian Premier League (IPL 10 or IPL 2017), the programme seems to have lost some of its sheen on the viewership numbers front. The programme has garnered combined weekly impressions (CWI) of 252.084 million impressions (sums) during the first 22 weeks of 2017 in the Hindi GEC (Urban+Rural) genre.

    Naagin 2 is also aired on Network 18’s second Hindi GEC Rishtey. On Rishtey, Naagin 2 was present for 8 of the first 22 weeks of 2017 in the weekly list of top five Hindi GEC (Urban+Rural) programmes at ranks 3, 4 and 5 on different weeks. On Rishtey, Naagin 2 had CWI of 75.340 million impressions while it was present in the top 5 Hindi GEC (Urban+Rural) genre. It must be noted that the actual sum of all the weekly impressions garnered by Naagin 2 were much higher if the weekly impressions of all the weeks during which it was aired on Rishtey are taken into accont.

    KumkumBhagya started sedately in week 1 of 2017, and it has generally shown slowly increasing viewership growth, during the first 22 weeks of 2017, even during the weeks that IPL 10 was aired. The programme garnered CWI of 242.145 million during the first of 2017 in the Hindi GEC(Urban+Rural) market. KumkumBhagya was ranked 1 for seven of the first 22 weeks of 2017, second for 11 of the first 22 weeks of 2017, third and fifth once each and fourth twice during the first 22 weeks of 2017.

    Please refer to the figure below:

    public://F1_9.jpg

    Naagin 2 was also the most watched programme in the weekly lists of the Top 5 Hindi GEC – Rural and Hindi GEC – Urban programmes during the first 22 weeks of 2017. It was present in the top five  programmes for the Hindi GEC Rural market for 16 of the first 22 weeks of 2017, with a total presence of 20 ranks across both of Network 18’s Hindi GEC channels – Colors as well as Rishtey.

    Naagin 2 was present in all the weekly list of the top 5 Hindi GEC – Urban programmes during all the first 22 weeks of 2017. It was ranked one for 18 of first 22 weeks, second and fourth for one week each and third for two weeks during the first 22 weeks of 2017.

    KumkumBhagya was present in the weekly lists of the Top 5 Hindi GEC – Rural programmes during 13 of first 22 weeks of 2017. It was ranked first and third for one week each, fourth for four weeks and fifth for seven weeks during the first 22 weeks of 2017. The programme was the third most watched Hindi GEC programme in the Hindi GEC – Rural space, after Naagin 2 and Balaveer on Sony Pictures Network India (SPN) channel Sony Pal

    KumkumBhagya was lapped up by Hindi GEC – Urban market- it was present in the weekly list of top 5 Hindi GEC Urban during all the first 22 weeks of 2017. It was ranked first for 4 weeks, second for five weeks, third for six weeks and fourth for seven weeks during the first 22 weeks of 2017.

     

  • Most watched Hindi GEC channels across genre until week 22

    BENGALURU: Three channels have been present during all the first 22 weeks of 2017 (Saturday, 31 December 2017 to Friday, 2 June 2017) in Broadcast Audience Research Council’s weekly list of Top 10 channels across genre-

    All India (U+R) : 2+ Individuals – They are (in order of the combined sum of weekly impressions while present in the top 10 channels across genre list) : Star Plus (16.128 billion CWI, Colors (13.67 billion CWI) and Zee TV (11.800 billion CWI).

    This paper is based on the information available in the public domain. Hence, It must be noted that the CWI figure mentioned in this paper is the sum of the weekly impressions of the channel mentioned in the BARC list of top 10 channels across genre – if a channel is not present in the list during any of the first 22 weeks of 2017, then its actual Combined Weekly Impressions will be much higher. Hence the author has refrained from mentioning the CWI for channels that were absent even for one of the first 22 weeks of 2017.

    None of the Hindi GEC channels have been ranked at no. 1 during the first 22 weeks of 2017 in the list.Star India has been ranked no 2 for 13weeks and Colors and Zee TV once each in the weekly list of Top 10 channels across genre during the first 22 weeks of 2017.

    Network 18’s second Hindi GEC – Rishtey was present in the weekly list of Top 10 channels across genre for 21 weeks; Sony Pictures Network India’s (SPN) Sony Pal was present in the for 16 of the first 22 weeks of 2017, followed by Zee Entertainment Enterprises Limited Hindi GEC – Zee Anmol which was present in the list for 13 of the first 22 weeks of 2017. The other channels that were present in the  list include SPN’sSony Entertainment Television, SPN’s Sony Sab, Star India’s StarUtsav and DD National during the period under consideration.

    Rank 1 has been held by the Sun TV Network’s flagship Tamil GEC Sun TV for 17 weeks and Hindi Movies channel Sony Max for five weeks (weeks 15 to 19 of 2017).SPN’sSony Max aired the tenth edition of the Indian Premier League (IPL 10 or IPL 2017) during the five weeks it was numerounoand the two weeks it was ranked second in the weekly list of Top 10 channels across genre. Sony Max had entered the weekly list of Top 10 channels across genre for the first time in week 14 of 2017 at rank 2. It was placed at rank 6 in week 22 of 2017.

    Top 10 channels across genre in week 22 of 2017

    public://11111111.jpg

     

  • BARC: CESP validates TV Measurement Panel Apr ’17 & Establishment Survey ’16 representativeness

    MUMBAI: The representativeness of BARC India’s Panel – the cornerstone of its TV Viewership measurement system – has been certified by CESP, a global multi-media body that audits media research. CESP is a joint industry committee that specializes in audience measurement audits and has worked in more than 20 countries. The certification further strengthens BARC India’s credentials of capturing “What India Watches”, basis a truly representative TV panel.

    CESP’s certification validates that BARC India in April 2017 has successfully aligned its research design and data collection methodology with the best international practices. BARC India has also received representativeness certification on Broadcast India 2016 – the Establishment Survey which was the basis for the new universe estimation that was rolled out earlier this year, and also forms the basis for ongoing panel home expansion.

    The certification has been awarded on the strength of quality benchmarks defined by BARC India Board and Technical Committee. The BARC India representativeness certification was also mapped against “Global Guidelines for Television Audience Measurement” (GGTAM) and CESP best practices based on panel audits conducted in more than 20 countries in the world.

    “CESP Scientific Committee fully certifies the representativeness of BARC India panel. Our Scientific Committee was really impressed with the quality of BARC India’s research design and deployment of panel homes. Considering the size of India and challenges for representativeness, the mission was fully achieved,” said Olivier Daufresne, Director of International Projects, CESP.

    “It is a proud moment for all of us at BARC India. Panel home selection is the key to true representation and robust TV viewership measurement. It is important to have the right mix of panel homes to be able to then extrapolate the data and report “What India Watches”. The certification is a stamp on the great work that our team has been doing,” said Partho Dasgupta, CEO, BARC India.

  • Dangal & programmes catapult Zee TV’s week 21 ratings

    BENGALURU: Zee TV, the flagship Hindi GEC channel of Zee Entertainment Enterprises Limited (Zeel) topped the HSM (U+R) : NCCS All : 2+ Individuals market ratings for the first time in in 2017 in week 21 – Saturday, 20 May 2017 to Friday, 26 May 2017. The channel garnered 679.456 million weekly impressions according to Broadcast Audience Research Council of India (BARC) data, the ninth highest ratings by a channel in 2017 until week 21 for the HSM (U+R) market.

    Zee TV was placed second in BARC’s weekly list of top 10 channels across genre – NCCS All India (U+R) : 2+ Individuals with 735.093 million weekly impressions. This was the eight highest ratings by any Hindi GEC channel in the across genre ratings. It may be noted that no Hindi GEC channels has ever topped the viewership across genre – that is a place that Sun TV reserved for itself (except during 5 of the 8 weeks during IPL 10). Hindi GEC’s have been ranked second for only14 of the first 21 weeks of 2017 in BARC’s lists for the most watched channels across genre.

    So what catapulted Zee TV to the top of the ratings chart among its peers in the HSM (U+R) and the across genre All India (U+R) charts?

    Zee TV’s success in week 21 can be attributed in part to the viewership of the world television premiere of Dangal; the viewership of its programme – Kumkum Bhagya and the viewership of the launch episode of a new soap opera – Aisi Deewangi Dekhi Nahi Kahi.

    The Aamir Khan starrer Dangal had an average viewership of 16.254 million on the day it was aired. Please refer to the chart below for the ratings garnered by the world television premiere of Dangal:

    Pragya and Abhi’s story – Kumkum Bhagya has taken the fancy of primetime viewers. It has been among BARC’s weekly top five most watched programmes list in the HSM (U+R), sometimes behind the Balaji Telefilms production – Naagin 2, for most of the first 21 weeks of 2017. However, Kumkum Bhagya has topping BARC’s weekly list of top five programmes (HSM (U+R) : NCCS All : Prime Time (1800 – 2330 hrs) : 2+ Individuals) for the past few weeks. In week 21, the programme had raked in 11.905 million weekly impressions, far ahead of Naagin 2’s 9.459 million impressions in the HSM (U+R) market.

    The launch episode of a new Indian Hindi soap opera on Zee TV – Aisi Deewangi Dekhi Nahi Kahi, improved the channels viewership in week 21 on launch day (Monday, 23 May 2017) 19:30 to 19:59 primetime slot by 72 percent as compared to the previous week. Please refer to chart below.

    The Eseel group television broadcast companies had a few more reasons to cheer in week 21 of 2017.

    The Zee News: Interview With UP CM “Yogi on Zee” improved viewership by 63 percent during the Wednesday – 19:55 – 20:48 slot as compared to the previous four weeks average. Please refer to the chart below:

    The Essel group celebrated its Ninetieth anniversary recently. The event was aired on 47 of the group’s television channels – it reached 75.96 million and attracted 27.65 gross impressions.

  • March: Max plaints against healthcare & education sector upheld by ASCI, news channels in list of 214

    MUMBAI: Although a maximum number of complaints upheld by ASCI were in the healthcare sector, tow of the news channels — TV Today (Aaj Tak) and TV 18 Broadcast (CNN News 18) also figured in the list against which complaints were upheld. ASCI’s Consumer Complaints Council (CCC), in March 2017, upheld complaints against 214 out of 280 advertisements. Of the 214 advertisements against which complaints were upheld, 175 belonged to the Healthcare category, 21 to the Education category, followed by seven in the Food & Beverages category and 11 advertisements from other categories.

    TV Today Network Ltd. (Aaj Tak): The advertisement’s claim, “Aaj Tak’s urban viewership crossed India TV’s All India Viewership” – Source : BARC, 08 Nov 16, TG 15+ NCCS AB, Time Band 2000-2400, imp’000, was not acceptable. It was noted that as per the recently circulated guidelines for Single Event reporting, the announcement of demonetization could be considered as single event reporting. However, the advertiser did not provide any data to show that impressions delivered are 25% above the same time band average for the previous four weeks or that impressions delivered are more than 20% of the full day impressions on the specified day, which is required as per the specific criteria in the BARC guidelines on Single Event reporting. This was in violation of the BARC principles and specific criteria for single event reporting.

    TV18 Broadcast Ltd. (CNN News18): The advertisement had the visual representation of charts suggesting the claims, “CNN-News18 is the No.1 English News Channel”. It was noted that the chart used in the advertisement violates the ‘Visual Representation’ Guidelines –   “Visual representations help the intended recipient of a commercial message. They must adhere to the following principles – Axes of a graph must be orthogonal, at 90°, Scaling must be linear, The Y-axis must generally intercept the X-axis at value 0. If an alternative value is used, this must be clearly indicated both on the chart and in its legend.” Though the complaint of misleading comparison was not considered to be objectionable, the visual representation shown is not in compliance with BARC Guidelines and therefore represents a misleading comparison. 

    HEALTHCARE:

    The CCC found the following claims of 175 advertisements in health care products or services to be either misleading or false or not adequately / scientifically substantiated and hence violating ASCI’s Code. Some of the health care products or services advertisements also contravened provisions of the Drug & Magic Remedies Act and Chapter 1.1 and III.4 of the ASCI Code. Complaints against the following advertisements were UPHELD.

     

      1.         Kolors Health Care India Pvt. Ltd. (Kolors Slimming & Beauty): The advertisement’s claim, “Five kilograms weight loss guarantee and five inch figure correction”, was inadequately substantiated and is misleading by gross exaggeration.  The efficacy being depicted via images of before and after the treatment is misleading by gross exaggeration.

     

      2.        Ayurwin Pharmaceutical Pvt. Ltd. (Nutrigain plus Powder & Capsules): The advertisement’s claims, “The only weight gain Product Powered by Ayurscience” and “Approved by Ayush Dept.”, were not substantiated with supporting evidence, and are misleading by gross exaggeration.

     

      3.       SBS Biotech (Dr Juneja’s Accumass): The advertisement’s claims, “Accumass is very helpful to gain weight”, “Increase body weight, not fat”, and pack claim, “Ayurvedic Formulation to help Gain Weight for all ages”, were not substantiated with supporting clinical evidence of product efficacy, and are misleading by exaggeration. Further the claims, “World’s Greatest Brands 2015-16 IUA” and “World Brand Summit – Most Trusted Brand of Asia 2016”, were not substantiated with any support data of the research or any comparative data versus other similar brands in the same category. The claims are not qualified to mention the source and date of research and criteria for assessment for the claims made. Also, the claims are misleading by ambiguity and omission.

     

      4.         SBS Biotech Ayurvedic Division (Roop Mantra  Skin Care Products): The advertisement’s claims, “World’s Greatest Brands 2015-16 IUA”, “India’s Most Trusted Brand – Consumer Validated 2015 – Voted By Indian Consumers”,  “Selected No.1 Brand India 2014 – Consumer Survey Report, Mrg 2014”, “World Brand Summit Dubai 2016 (Ayurvedic Otc Products) Conducted By : World Brands Review Corporation”, “Most Trusted Brand Of Asia 2016”, were not substantiated with any support data of the research or any comparative data versus other similar brands in the same category. The claims are not qualified to mention the source and date of research and criteria for assessment for the claims made. Also, the claims are misleading by ambiguity and omission of the product category. 

     

      5.          Dr. Batra’s Positive Health Clinic (Dr. Batra’s Homeopathy): The advertisement’s claims, “Our treatment results are independently audited by American Quality Assessors (AQA) across our patient base of 15 lakh, and are as follows: – All Ailments – 94% Better – Hair Loss – 95% Better – Skin Diseases – 88% Better – Women’s Problems – 94% Better – Child Disorders – 94% Better”, were not substantiated with authentic supporting evidence nor any independent audit or verification certificate, and are misleading by exaggeration. 

     

      6.          Dr Batra’s Homeopathic Clinic: The advertisement’s claims, “We have successfully treated more than ten lakh patients having Skin conditions, Women’s disease, High sugar levels,  Overweight, Sexual Problems, in every age person” and the visual implying cure of Leucoderma are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      7.          Ayushakti Ayurved Pvt. Ltd. (Ayushakti Ayur Health Centre): The advertisement’s claims, “Even the Phoenix House Foundation in the U.S.A. believes Ayushakti doctor are the best in giving solutions for breathlessness, allergies and depression”, “Ayushakti helped rescue workers of 9/11 attack to come out of shock, depression, severe breathlessness, joints pain and chronic fatigue”, “Within 18 months 80% of the people did not need any breathing pumps. Their frequent allergy problems, breathlessness and depression had relieved remarkably and they all started working again”, “The Phoenix House Foundation U.S.A research proves Ayushakti herbs are effective in combating breathing difficulties, joint pain, chronic fatigue and depression”, “In general, Ayushakti’s herbs proved to be the most effective after six months!”,  “Continuing the  rejuvenation herbs in the Asthatox program, helps nourish the channels, thus protecting your lungs from further damage and promotes easy breath” and “Asthatox detox provides remarkable results in just two months. If you follow only herbs and diet, then you get relief from symptoms in six months to a year”, Ayushakti has helped lacs of people for the past 27 years to relieve chronic ailments like joint pain, breathlessness, high blood sugar, skin and hair problems, gas -acidity, IBS, weight gain, unable to experience parenthood”, were inadequately substantiated and are misleading by gross exaggeration.

     

      8.          Kalpayur Ayurvedic Clinic & Panchakarma Center (Diabecare): The advertisement’s claim, “Diabecare – Natural & Effective Support in Diabetes. Yogic Naturals with Active Nano Extracts”, was not substantiated with supporting clinical evidence and is misleading.

     

      9.           Simandar Herbal Pvt. Ltd. (Yesaka Sugar Free Liquid): In the advertisement’s claim, the product name, “Yesaka Sugar Free Liquid” for product meant for treatment of diabetes, is misleading by implication. The product name when read in conjunction with the tagline, “curing naturally” and visual showing a Glucometer,  implies that the product is beneficial in curing diabetes, which is in breach of the law as it violated the Drugs & Magic Remedies Act (DMR Act).

     

      10.         The Pain Clinic: The advertisement’s claim (in Gujarati) as translated into English, “Treatment without operation”, was not substantiated with clinical evidence of the treatment efficacy and is misleading by gross exaggeration. 

     

      11.          Prettislim Clinic: The advertisement’s claim, “Winner of Best Healthcare Brand 2016 Award” was inadequately substantiated and the claim is misleading by omission and ambiguity. Further for the claim, “No1 slimming Clinic in Mumbai”, while the advertiser presented reference of All India Lifestyle Hospitals and Clinic survey 2016 mentioning Prettislim as No.1 Bariatric clinic, its mention as No. 1 slimming clinic was not considered acceptable and was considered to be misleading by ambiguity. Also the claim, “Thousands of satisfied customers who have given us 95% satisfaction ratings”, it was noted that the data provided by the advertiser is self-certified. In absence of any third party validation, this data was not considered to be unbiased and reliable.

     

      12.          Slim Trim Point: The advertisement’s claims, “Five kilograms + 20-25 centimeters in six hours”, “Ten kilograms + 35-40 centimeters in 12 hours”, “20 kilograms + 55-60 centimeters in 24 hours”, were not substantiated with supporting clinical evidence, and with treatment efficacy data,  and are misleading by exaggeration.

     

      13.          GEHM Clinic and Research Center (Fit Forte Tablets): The advertisement’s claim, “Fit Forte Tablets -To reduce body weight”, was not substantiated with evidence of product efficacy, and is misleading. Visual shown in the advertisement implies significant weight loss, which is misleading by implication. 

     

      14.          Eye-Q Vision Ltd.: The advertisement’s claims, “Most Trusted Brand” was inadequately substantiated. The claim does not cite the source and date of research and is misleading by omission of the mention of the sub-category for the award.

     

      15.           Lifezen Pvt. Ltd. Healthcare: The advertisement’s claims, “Better QUALITY  Better RELIEF  Better PRICE”, were not substantiated with verifiable comparative data versus other similar products in the same category, and are misleading by exaggeration and implication that other eye drops products are inferior to the advertised product.  

     

      16.           Shahjadi Pharmaceutical Private Limited (Ab Love Day): The advertisement’s claims, “Ab Love Day- Trusted, Effective and Convenient”, “Two tablets keeps you from getting pregnant for six months”, “Freedom from regular intake of tablets” and “Safe, Effective and Easy way to keep age gap between children”, were not substantiated with clinical evidence, and are misleading by gross exaggeration.

     

      17.            Chemical Resources (GCB 70): The advertisement’s claims, “Better Body, Better Life”,  “Burn both sugar and fat & slow the release of sugar into blood stream”,  “Preserve natural antioxidants in the body”,  “Decrease waist circumference & BMI”,  “Clinically Evaluated”  and “GCB 70 supports healthy metabolism”, were inadequately substantiated.  Also, the claims are misleading by ambiguity and implication. 

     

      18.             Yashna Enterprises (No Blu Glasses): The advertisement’s claims, “Get 5X Sharper Visual Detail and 10X Reduced Eye Strain!” were not substantiated and are misleading by gross exaggeration.

     

      19.             GBR Clinic-Fertility Centre: The advertisement’s claims, “Being the No.1 Fertility Clinic in Chennai & Tamil Nadu, we have been providing very high success rate consistently every month”. It was noted that the advertiser has not provided any authentic, independent, verifiable comparative data versus other similar clinics in the same category or any third party validation or research to prove this claim, and the claim is misleading by exaggeration and implication that they would cure infertility. Additionally, this is in breach of the law as it violated the DMR Act.  

     

      20.              Vaidya Revati Prasad (112 salki burhia ki ghuti): The advertisement’s claims, “Enriched with calcium & iron” and “Makes children healthy & strong”, were inadequately substantiated with evidence of product content analysis and efficacy.  Also, the claims are misleading by ambiguity.

     

      21.              OPTM Health Care (P) Ltd. (UR Halt): The advertisement’s claims, “URHALT- Control Naturally” and “Presenting URhalt – clinically evaluated, natural oil that can regain control of your overactive bladder”, were inadequately substantiated and are misleading by exaggeration.  

     

      22.               Ayurved Sumshodhanalaya Pvt. Ltd. (Kailas Jeevan multipurpose Ayurvedic cream): The advertisement’s claims, “Take a teaspoonful of K J Cream with equal amount of ground sugar before bed time.  Brings relief from piles” and “Effective on burning sensation in Burns, Wounds and Cuts also” were inadequately substantiated, and are misleading.

     

      23.               Gaudium IVF Centre (Gaudium Kare IVF): The advertisement’s claims, “Delivering highest success rate across the Country”, was not substantiated with verifiable comparative data versus other similar clinics in the same category or any third party validation or research to prove this claim. Further the claim, “High Success rate even in failed IVF cases”, was not adequately substantiated with supporting data.  Also, the claims are misleading by gross exaggeration and implication of assured child for childless couples. It was also considered that the advertisement with reference to infertility “treatment” was in violation of the DMR regulations / The Drugs & Cosmetics Rules (D&C Act).

     

      24.               Srikara Hospital: The advertisement’s claim, “No.1 Centre for OXINIUM Knee Replacements”, was not substantiated with any verifiable comparative data versus other similar clinics in the same category or any third party validation or research, and is misleading by exaggeration. 

     

      25.               Manjeeram Holistic Centre:  The advertisement’s claim, “Provides treatment for any kind of diseases without any medicine”, was not substantiated with supporting clinical evidence, and with treatment efficacy data among patients, and is misleading by gross exaggeration.

     

      26.              Kudos Laboratories India Limited (V-1 Capsules and Jointment): The advertisement’s claim, “First time the most-cheapest solution for joint pains in India”, was not substantiated with comparative data versus other similar products in the same category. Further the claim, “Does not have side effect”, was considered to be an absolute claim and was not substantiated with clinical evidence. The claims, “Lac of people have accepted the tablet”, was not substantiated with supporting data. Also, the claims are misleading by gross exaggeration. The claims referring to Central Ministers praising the product, and Government of India letter endorsing the product, were misleading by ambiguity and were in violation of the Emblems and Names (Prevention of Improper Use) Act. The testimonials used in the advertisement imply cure from arthritis and were in contravention of the DMR Act.

     

      27.              Kudos Ayurveda (Kudos Maharaja): The advertisement’s claims, “Now more power”, “Get Back the Fire”, “Kudos Maharaja makes married life more exciting” and the visual in the advertisement and package, read in conjunction with the claims made in the advertisement imply that the product is meant for enhancement of sexual pleasure and are considered to be, prima facie, in violation of the D&C Act.

     

      28.             Kudos Laboratories India Limited (Kudos V1 Capsule and Jointment): The advertisement’s claims, “If you want to say goodbye for joint pain then now accept V1 (14:47)” and “Complete treatment for joint pain (00:53)” and the visual in the advertisement (2:08 and 17:03 -For Rheumatoid Arthritis V1) implies that the product is meant for treatment / cure of Rheumatism. This is considered to be, prima facie, in violation of the DMR Act.

     

      29.              Jeewan Jyoti Pharmacy Pvt. Ltd. (Health Sun Range Of Products): The advertisement’s claims, “If you are thin then don’t be sad, Health sun capsules and powder helps to eliminate your thinness, Repairs blood circulation and helpful in increasing weight by removing lack of mental and physical development”, “Increase body weight not fat” and “Health sun capsules and powder helps to eliminate your thinness and Repairs blood circulation and bring body in shape and beautiful”, were not substantiated with supporting clinical evidence of product efficacy. Further the claims, “This is trusted certified Ayurvedic Medicine and is fully safe”, was not substantiated with supporting data. Also, the claims are misleading by exaggeration.

     

    30.               Trophic Wellness Pvt. Ltd. (Nutricharge – Man Tablet): The advertisement’s claims, “Helps meet daily needs of Vitamins and Minerals”, “Provides 35 vitamins, minerals, amino acids and antioxidants”,  “Provides most vital nutrients in required quantity to prevent nutritional deficiencies, helps to maintain function and structure of various organ systems and may be beneficial for cardiovascular health and in diabetes”,  “not harmful for a person with diabetes”,  “Works specifically for correcting dietary deficiencies only and does not increase weight “,  “Non habit forming” and “May be beneficial if you are on a special diet or dieting as it provides valuable vitamins, minerals and amino acids which you may not get from your strict diet”, were not substantiated with clinical evidence or proof of efficacy for the product, and are misleading by exaggeration.

     

      31.            Trophic Wellness Pvt. Ltd. (Nutricharge Prodiet): The advertisement’s claims, “Contains high quality Soy protein isolate from DuPont USA, dietary fiber from Matsutani, Japan and cocoa from Belgium”, “Take 1 tablet of Nutricharge Man with 1 glass of Nutricharge ProDiet shake, in the morning to fulfill your daily needs of Protein, Vitamins, Minerals and Fiber”,  FAQ: “being an excellent source of protein can be taken daily in recommended dose to help fill the gap in our protein nutrition”, FAQ: “provides hi-quality purified and processed soya protein which may help enhance physical strength and boost immunity. For getting all key minerals and vitamins adults should take one tablet of Nutricharge Man/ Woman also daily” and FAQ: “an excellent supplement containing high quality protein besides iron, folic acid and calcium”, were not substantiated with supporting proof, and are misleading.

     

      32.            Trophic Wellness Pvt. Ltd. (Nutricharge Kids): The advertisement’s claims, “For the first time in India, a special chocolate flavoured supplement for children that contains 49 nutrients” and “Three type of protein, 15 vitamins, 14 minerals, fiber, ten botanicals other macromolecules, three pre-pro biotics and two amino acids.”, were not substantiated with supporting data. Further the claim, “It helps in improving brain development, boost immunity and promote growth”, was not substantiated with evidence of product efficacy. Also, the claims are misleading by exaggeration.

     

      33.            Trophic Wellness Pvt. Ltd. (Nutricharge Health Drink): The advertisement’s claims, “Energy revitalizing beverage”, “Enriched with Minerals and Electrolytes to hydrate the body”, “Energy boosters like Taurine and Vitamins” and “One can consume it when one feels low on energy, de-hydrated, refreshment and thirst”, were not substantiated with proof of efficacy. Further the claim, “Contains natural Pomegranate and Red Grape juice from USA and Spain”, was not substantiated with supporting data. Also, the claims are misleading by exaggeration.

     

      34.            Trophic Wellness Pvt. Ltd. (Nutricharge): The advertisement’s claims, “Clinical Trials prove Nutricharge efficacy and safety” and “Nutricharge products are health supplements “ were not substantiated and are misleading.

     

      35.            Trophic Wellness Pvt. Ltd. (Nutricharge Products): The advertisement’s claim, “The Most Awarded Wellness Brand”, is an absolute claim and is not substantiated with any comparative data versus other brands, and is misleading by exaggeration.

     

      36.            Shree Baidyanath Ayurved Bhawan Pvt. (Baidyanath Arjunamrita): The advertisement’s claims, “As Arjunamrut is enriched with herbs like Naagkeshar and Lotus Flower it is more beneficial” and “More Effective than Ordinary Arjunarishta”, were not substantiated with product efficacy data, and are misleading by exaggeration.

     

      37.            Shree Baidyanath Ayurved Bhawan (Baidyanath Vita Ex Gold Plus): The visual in the advertisement and the product packaging read in conjunction with the claims in the advertisement implies that the product is meant for enhancement of sexual pleasure which is considered to be, prima facie, in violation of the D&C Act.

     

      38.            Shree Kalyan Ayurvedashram: The advertisement’s claims, “Acclaimed by thousands of patients having suffering from spots” and “After starting treatment the color of spots change & instantly all spots get removed and skin color gets uniform”, are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

      39.           Shree Maruti Herbal (Stay On Power Capsules): The advertisement’s claim, “Effective for Energy, Excitement and Power” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      40.           Shree Maruti Herbal (Stay On Oral Liquid): The visuals and claims in the advertisement imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

      41.          Shree Maruti Herbal (Stay-On Power Oil): The advertisement’s claim, “Massage daily and experience the height of happiness Only for Men” and the visual in the advertisement and package, read in conjunction with the claims objected to imply that the treatment is meant for enhancement of sexual pleasure and are considered to be, prima facie, in violation of the D&C Act.

     

      42.          Shree Maruti Herbal (Stay on Power Capsule): The advertisement’s claim, “Feeling of Strength and Absolute Vigour” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

      43.          Shree Maruti Herbal (Stay on Power Capsules): The advertisement’s claim, “This is the opportunity to give energy to the sperms” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim objected to, imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      44.           Shree Maruti Herbal (Stay on Power Capsules): The advertisement’s claim, “Feel the power. Hour – after – hour” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      45.         Shree Maruti Herbal (Stay on Power Capsules): The advertisement’s claim, “Helpful for Energy, Excitement and Power” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      46.         Shree Maruti Herbal (Stay On Power Capsules): The advertisement’s claim, “Effective for Energy, Excitement and Power” and the visuals in the advertisement, product packaging and product name read in conjunction with the claim in the advertisement imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

      47.         Shree Maruti Herbal (Stay On Oral Liquid): The visuals and claims in the advertisement imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

      48.         Shree Maruti Herbal (Stay On Power Oil): The advertisement’s claims, “Physical Deficiency? Lack of Excitement? Loose Organ? Strengthen the loose organs and helps to make fresh sperm counts”, “Massage daily and experience the HEIGHT of HAPPINESS” and the visuals in the advertisement, product packaging and the product name read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure, were considered to be, prima facie, in violation of the D&C Act.

     

      49.         Shree Maruti Herbal (Stay-On Range of Products): The visuals in the advertisement, product packaging and the product name imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

      50.         Tasmiya Retail Private Limited (Beauty 4ever Permanent Hair Removal Cream): The advertisement’s claims, “Get rid of unwanted hair through cream”, “For both Women & Men, apply just twice” and “Permanent hair removal cream”, were not substantiated with product efficacy data, and are misleading by exaggeration. Also, efficacy being depicted via images of before and after the use of the product are misleading.

     

      51.        Dr Bhavana Shah Fitness Highway (Vela weight loss, U-Lipo and Tummy tuck): The advertisement’s claim, “Lose ten kilograms in ten weeks”, was not substantiated with supporting clinical evidence, and with treatment efficacy data, and is misleading by exaggeration. There was no reference to Rs. 30,000/- in the package claimed in the advertisement. Further the claim offers, “U-Lipo FREE!!!*”, “Tummy Tuck FREE!!!*” and “Six months maintenance free!!!*”, are misleading by ambiguity and omission as the services offered are not free but subject to purchase of package of Rs.30,000/-.

     

      52.        Dr. Bhavana Shah’s Fitness Care Pvt. Ltd. (Dr. Bhavana Shah’s Fitness Highway): The advertisement’s claims, “Fantastic Results with Signature FAT FREEZEE Crylipolysis”, “Spot Reduction” and “Lose upto eight centimeters to ten centimeters in Fat Freeze*, Lose upto 1/2 kg to 1 kg in Fat Freeze*”, were not substantiated with supporting clinical evidence, and with treatment efficacy data, and are misleading by exaggeration.  The visual of a slim waistline in the advertisement was considered to be misleading by implication.

     

      53.        Dr. Mehul’s The Slimming Clinic (The Slimming Clinic): The advertisement’s claim (in Gujarati), as translated into English, “Weight loss upto six kilograms in one month & fifteen centimeters in one session”, was not substantiated with supporting clinical evidence, and with treatment efficacy data,  and is misleading by exaggeration.

     

      54.       Angels Advanced Clinic Private Limited (Angels Advanced Clinic): The advertisement’s claims, “Want to Improve Entire Body Colour Complexion?-First time in India, Angels introduced, Proven World Class GSH Technology. Make your dream of improving Entire Body Colour come true” and “For Dense Hair Stem Cell Therapy  Angels STEMCELL Therapy which is a Universal Technology controls Hair fall, not only prevents Bald Head but also brings new hair growth for hair thinning and semi bald head”, were not substantiated with clinical evidence and with treatment efficacy data, and are misleading by gross exaggeration. The efficacy being depicted via images of before and after the treatment are misleading by gross exaggeration.

     

      55.      High Hopes: The advertisement’s claims (in Gujarati), as translated into English, “No Exercise  No Gym”,  and “Reduce weight upto 10 kg in 3 months through scientific Method”, were not substantiated with supporting clinical evidence, and with treatment efficacy data,  and are misleading by exaggeration. The efficacy being depicted via images of before and after the treatment is misleading by gross exaggeration.

     

      56.      Zee Laboratories Limited (Zee Myfair Cream): The advertisement’s claim, “President Award Winner”, was not substantiated with details of the award and references of the award received such as the year, source and category. Further the claim, “India’s Most Favourite”, was not substantiated with any verifiable comparative data versus other similar fairness creams in the same category or any third party validation or research to prove this claim.  Also, the claims are misleading by exaggeration. 

     

      57.      Life Homeopathy: The advertisement’s claim, “Without Operation: Piles, Fistula, Tumours” and the misleading testimonial which implies cure for asthma, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      58.     Sardar Ji Skin Cure: The advertisement has reference to White Spots (vitiligo). It is misleading by ambiguity and implication and is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      59.     Lord Pharma Company (Mehanorm Plus): The advertisement’s claim, “Sure treatment of diabetes”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

      60.     Sun Laboratories (P) Ltd. (Titanic-K2 Capsules): The advertisement’s claims, “Now Titanic-K2 with full energy” and “Power Booster for Men”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Ayur Veda Mantra: The advertisement’s claims, “Cure in 14 Days Cervical Spondylosis, Lumbar Spondylosis and Parkinsonism”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Mata Tirath Devi Ayurvedic Hospital: The advertisement’s claim, “Ayurvedic treatment of cancer”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Dr Shukla Ayurvedic Sex Clinic: The advertisement’s claims, “Meet for masculine weakness, nightfall, premature ejaculation, discharge, childlessness, lack of sperm & every veneral diseases.”, “Get New strength and youth in growing age” and the visuals in the advertisement read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure, and are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Cenozoic Remedies Pvt. Ltd. (Diaba Dops Liquid & Capsules): The advertisement’s claim, “Now sugar treatment from roots”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Star Ayurveda (Star Homeopathy/Star Ayurveda): The advertisement’s claims, “Safe, perfect treatment for all types Chronic Health Diseases ….. Treatment without operation. Put an end to Asthama, Obesity, Diabetes, Infertility Problems, Rheumatoid Arthritis, and Ankylosing Spondylitis”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Star Ayurveda: The advertisement’s claims, “Guaranteed treatment for all chronic health diseases,” “Permanent Solution for chronic diseases like piles, fissure, fistula, kidney disorders! Along with this special treatment for Neurological Disorders, Liver and Digestion related problem without operation,” and “Joint Pains, Sciatica, Adenoids, Spondylitis, Tonsils, Stones in Kidneys” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.       Star Ayurveda (Star Homeopathy): The advertisement’s claim, “Cervical Spondylitis, Arthritis, Piles, Fissures, Fistula, Kidney Stones- No Operation, No Pain Killers,” and the claims imply cure from these conditions. This is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Star Ayurveda (Star Homeopathy): The advertisement’s claim, “Solution without operation for chronic diseases like piles, fissure, fistula, Spondylitis, Stones in Kidney,” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.     Charak Kayakalp Hospital: The advertisement’s claims, “Get rid of Asthma quickly” and “Kidney failure patients are taking benefits through panchkarma treatment and getting rid of dialysis”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Olivet Pharma Pvt. Ltd. (Ayusya Ayurvedic Super Speciality Treatment): The advertisement’s claims, “Get a pain free life with the process of ayurvedic Panchakarma, treat Rheumatoid Arthritis, Psoriatic Spondylitis, Cervical and Lumber Spondylitis and Leucoderma”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Soliel International Healthcare Products (BT-36 Body toner capsule and cream): The advertisement’s claim, “Beautiful shape” and the visual in the advertisement, read in conjunction with the claim objected to, imply that the product is meant for breast enhancement. The claim is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Positive Homeopathy: The advertisement’s claims, “Excellent Safe treatment by experts in skin disease. To any problem, easy and safe process treatment- Infertility Piles, Diabetes, Spondylitis”, “Complete cure of diseases with nano pills-Diabetes, Piles, Arthritis, Infertility, Hepatitis”, “100% Cure is our priority” and the visual implies cure for Leucoderma, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Positive Homeopathy: The advertisement’s claims, “100% Cure is Our Priority”, “Treatment with Nano pills through Advanced Nano Medicine and Genetic Method for the first time in world, Diabetes, Commplete Treatment to Piles, Fistula and Fissures, Hepatitis-B Free from breathing related problems, Asthma Motherhood is Blessing, Make it success, Good solution”, “PCOD, Infertility, Hormones problems, Over Weight”, “End to Sex problems,” “ED problems, Sexual Depression, Hormones,” and “Complete treatment to Piles, Fistula, & fissure” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.       Positive Homeopathy:  The advertisement’s claim, “Get rid of from Piles/Fissures/Fistula,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Meeta Ayurveda: The advertisement’s claims, “Increase sex time upto 35 minutes”, “Take advice and treatment for penis length/ increase thickness, discharge, thinness, loose organ, sloping organ” and the visual in the advertisement, read in conjunction with the claims objected to imply that the treatment is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Ayurved Amrutam: The advertisement’s claims, “Successful treatment of patients disappointed by other medical methods- Obesity, Diabetes, Women’s Diseases, White spots, Hepatitis, Liver cyst, Fatty Liver, Venereal diseases, Stomach diseases- Ulcers, Piles, Kidney Stones,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.       Ayurved Amrutam: The advertisement’s claims, “Successful treatment of patients disappointed by other medical method” and “Relief from the beginning in excessive pain, Cervical, Arthritis, Obesity, Diabetes, White Spots, Liver, Hepatitis, Fatty, Liver, Kidney Stone, Ulcer, Piles, Female Diseases” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Ratan Ayurvedic Sansthan (Sudol Body Toner Capsules): The advertisement’s claims, “It has raised confidence of generations”, “Used by millions of females, Get amazing confidence with sudol” and the package visual implies that the product is meant for breast enhancement are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Raheem Unani Clinic: The advertisement’s claims, “Excellent Treatment for Lost Sexual desires, Masturbation, Quick Ejaculation, Sexual Dissatisfaction, Infertility and other sexual related problems”  and the visual in the advertisement, read in conjunction with the claims objected to imply that the treatment is meant for enhancement of sexual pleasure, treatment without operation, for removal of stones in Kidneys. Also, the visual in the advertisement, implies cure for Leucoderma are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    G M Ayurved: The advertisement’s claims, “Increase height. Two – six inches, course duration four months, result from the first month”, “Remove obesity, Reduce extra fat and weight”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Dr. Dassan’s life Care Ayurvedic Herbal Treatment and Research Centre: The advertisement’s claims, “Patient of hemiplegia          and paralysis who was unable to speak is able to speak again”, “Three months of treatment with Dr. Dassans he has his got speech back and is able to walk again” and the testimonial claims cure for paralysis, are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.    Dr Dassans Ayur Neuro Treat & Res Cent: The advertisement’s claim, “We can survive from Kidney Disease and Dialysis”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Play Win Capsule): The advertisement’s claims, “Gives vigour & enormous pleasure” and the visual in the advertisement, imply that the treatment is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin Capsule): The advertisement’s claim, “More enjoyment that will make your partner excited, Helps control premature ejaculation” and the visual in the advertisement, read in conjunction with the claims objected to imply that the product is meant for improvement of sexual capacity. These are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin plus Capsule): The advertisement’s claims, “Increases passion, strength, extra timing and pep” and “helps stop premature ejaculation”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claims, “Forget the world when you have loads of vigour”, “Increases vigour, strength, Energy & pep!” and the visuals in the advertisement read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Take pleasure of married life with more vigour,” and the visuals in the advertisement read in conjunction with the claim objected to implies that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Make your Valentine Day More Special with PLAY WIN,” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Make your relationship stronger” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Capsules): The advertisement’s claim, “Helps prevent Premature Ejaculation” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin Plus Capsules): The advertisement’s claims, “Make your Valentine Day Special with Play Win Plus”, “Make your relationship more stronger” and the visuals in the advertisement read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Playwin plus Capsules): The advertisement’s claim, “The success of happy married life, make your relationship stronger” and the visuals in the advertisement read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

    1.       Rajnish Hot Deals Pvt. Ltd. (Kasaav Dusting Powder): The advertisement’s claims, “KASAAV dusting powder – Create the beautiful moments in life, Kasaav gives the feeling of infancy in you”, “Best result in first use”, “Have the feeling of virginity” and “Kasaav powder is prepared by precious ayurvedic herbal mixture which helps to prevent the problem of loosening of vagina by making muscles tight and gives liveliest young feel to woman.  Kasaav powder is 15 days course will prevent the old memories and gives new hope and praise” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Dindayal Aushadhi Pvt. Ltd. (303 Capsules): The advertisement’s claim, “Use 303 at Night” and the visual in the advertisement, read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure and is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Dindayal Aushadhi Pvt. Ltd. (303 Capsules): The advertisement’s claim, “Today or Tomorrow enjoy every moment” and the visuals in the advertisement read in conjunction with the claim objected to imply that the product is meant for enhancement of sexual pleasure, is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Jeevan Jyoti Group of Hosp. (Arpit Test Tube Baby Center): The advertisement’s claim, “Complete and successful treatment for childlessness”, is considered to be, prima facie, in violation of the DMR Act.

     

    1.    Dr. Kamlesh Tandon Hospital and Test Tube Baby Centre: The advertisement’s claims, “Good news for childless couple – Now becoming mother is very easy through test tube method” and “Majority of patients succeeded with this scheme and taking healthy children to their homes”, are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Akashdeep Hospital: The advertisement’s claim, “Successful Treatment centre for Epilepsy, Stroke”,  is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Rohilkhand Medical College and Hospital: The advertisement’s claims, “Successful treatment of uterus, tumors & cancer”, “Infertility treatment” and “All types of female diseases treated”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

     

    1.    Rejuvenate Hair Transplant Centre: The advertisement’s claim, “Rejuvenate presents effective and instant treatment through cosmetic surgery for freezed white spots which is incurable with medicine”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Vijaya Diagnostic Centre: The advertisement’s claims, “Lose Weight & Never Regain” and “Resolves – Diabetes, Hypertension, Heart Disease, Arthritis, Infertility”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Shri Ram Hospital: The advertisement’s claims, “Riddance to following diseases by obesity surgery:  Diabetes, Heart problems/Blood pressure.” and the before and after weight loss visuals appear to be misleading and imply cure from obesity, and are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Chellaram Diabetes Institute (Chellaram Diabetes Hospital): The advertisement’s claim, “Diabetes with Obesity is Curable Now!” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Mohans Medicity Hospital: The advertisement’s claims, “Rule Out Women Cancers – In just two hours” and “Ultimate destination, for cancer cure”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Guru Hospital: The advertisement’s claim, “Cancer Cure without side effect by HI END linear accelerator with advanced technology”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Columbia Asia Hospital (Nobesity Centre): The advertisement’s claim, “Nobesity Centre – The name of centre implies cure from Obesity”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Sneha Counseling Centre (Sneha Clinic & Counseling Centre): The advertisement’s claim, “We provide medicines for depression, autism 100% cure”, is considered to be, prima facie, in violation of the DMR Act.

     

    1.    Dr. Tembe Hospital: The advertisement’s claim, “Effective Treatment for white spots”, is considered to be, prima facie, in violation of the DMR Act and  the D&C Act.

     

    1.    Slim-N-Health: The advertisement’s claims, “Eliminate Obesity by reducing Fat permanently and helpful in keeping away related diseases (Health Problems like Diabetes, Heart Problems, Bones & joint pains, Gynaec Problems, Hypertension, etc)”, are considered to be, prima facie, in violation of the DMR Act and  the D&C Act.

     

    1.    Mane Medical Foundation: The advertisement’s claim, “Successful treatment on white spots and Psoriasis” and the visuals in the advertisement read in conjunction with the claims in the advertisement implies that they offer a cure for white spots and Psoriasis and are considered to be, prima facie, in violation of the DMR Act and  the D&C Act.

     

    1.    Nurture Health Care (Ayurex S): The advertisement’s claim, “Experience of vigour and youthfulness in veins for weakness due to premature ejaculation”, is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Amrita homeopathy: The advertisement’s claims, “INFERTILITY? IVF FAILURE? Worry no more! Meet our Experts!” and “Now your dream of having a baby will be a reality soon”, are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Dr Richas Unique Clinic: The advertisement’s claim, “Height Treatment/ Ladies Bust Enlargement, Reduction Firming”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Sugar Control Clinic: The advertisement claims, “Sugar control clinic” and “can control sugar when all other options fail”, is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Khushi Ayurveda Pvt. Ltd. (Khushi Ayurveda Range Of Products): The advertisement’s claims, “100% effective treatment for Piles without any operation pain” and “Ten days of this course gives freedom from chronic piles and the pile warts permanently”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Capital Pharmacy (Attari Tel): The advertisement’s claims, “Yunani Medicine with guarantee for Paralysis, Arthritis” and “ATTARI Hemorrhoids Syrup – During Haemorrhoids drinking 2-2 spoons in morning and evening will stop the blood in haemorrhoids. By continuously drinking for three months, Bleeding Haemorrhoids will be cured completely”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Dr Rajesh Upadhyay Ksharsutra Clinic: The advertisement’s claim, “1st time in Agra successful treatment of piles, fistula & fissure through foreign machine, new technique, cryotherapy and kshar sutra”, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Homeo Trends: The advertisement’s claims, “Confidence Solution to Sex Problems: Premature ejaculation, Right Solution to Infertility problems in Women, Excellent medicines in Homeo for Infertility problem compared to other medical procedures”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Grovel Drugs & Chemicals Pvt. Ltd. (Amrutha Dia Churnam): The advertisement’s claims, “Controls Diabetes, For Diabetic suffers (sugar patients), GROVEL presents an Elixir medicine”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Chaturbhuj Pharmaceuticals (Japani Oil): The advertisement’s claims, “For mellowness in Married Life, Specially Famous and Effective for Manly Power, The feeling of energy, stamina and Power” and the visuals in the advertisement and packaging read in conjunction with the claims objected to imply that the product is meant for enhancement of sexual pleasure. These claims are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Chaturbhuj Pharmaceuticals (Right Sugar Tablet): The advertisement’s claims, “Yes, Diabetes (Sugar) control now possible” and “Right sugar tablet works as the name is”, are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Hair Mantras: The advertisement’s claim, “New medicine will give riddance from baldness,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.     Ruchi Herbals Pvt. Ltd. (Long Dive Range of Products): The advertisement’s claim, “Tell your problem and get the solution” and the visuals in the advertisement, product packaging and the product name imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Ruchi Herbals Pvt. Ltd. (Long Dive Range of Products): The visuals in the advertisement, product packaging and the product name imply that the product is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Classical Homoeopath (Dr Mitwar): The advertisement’s claim, “Permanent treatment of genetic and incurable diseases,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Heart & Health Care: The advertisement’s claims, “For happy married life”, “Now it’s possible to get rid of diabetes from roots” and  “Take successful treatment of masculine weakness, premature ejaculation, lack of sperm, discharge, undeveloped organ,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    B K Arogyam & Research Center: The advertisement’s claims, “Permanent treatment for Kidney and Urethral stones”, “Get freedom without operation by experienced ayurvedic doctors” and “Get treatment for Kidney tumour,  piles, Gonorrhea and all kind of female and male venereal diseases,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Devarshi Ayurved & Biotech Pvt Ltd (Devarshi Ayurved Range of Products): The advertisement’s claim, “Diabicure Product name implies cure from diabetes” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Muniraj Ayurved Ashram (Muniraj Arsh Hari): The advertisement’s claims, “Sure shot medicine to remove piles”, “Successful ayurvedic medicine for all diseases like Piles, anal warts, Gonorrhea, Dysentery, fistula, cough etc.” and the product name imply cure from piles, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Raj Pharmacy: The advertisement’s claim, “Disappointed from everywhere. Guaranteed treatment from roots without surgery for Piles, Fistula, fissure, hydrocele,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Technopharm (Horse Power Capsules): The advertisement’s claims, “For women and men”, “Lack of semen and absence of sperm in it” and “Lack of interest in sex, anaemic,” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Mahaguni Ayurveda Pvt. Ltd. (Mahaguni Ayurveda Range of Products): The advertisement’s claims, “Remove physical weakness”, “Take pleasure of married life” and the visuals in the advertisment read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure, are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Juneja Clinic (Juneja Modern Clinic): The advertisement’s claims, “Sex problems – men disease, Take seven days course of strength, premature ejaculation, Masculine weakness, loose nerves, undeveloped organ, thinness, Sloppy and less sperm,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Lord Dhanvantari Hospital: The advertisement’s claims, “Finish from root of arthritis and Joint pain” and “100% Ayurvedic treatment from root for arthritis – joint pain – Hip, Joint Pain, waist pain, cervical, spondylolysis without operation,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.     Olefia Biopharma Ltd. (Votif Syrup): The advertisement’s claims, “Votif Syrup – For all Sex Related Problems”, “Lack of sex desire or no willingness”, “Less or weak sperm. – Inability to complete the action of fertility”, “Decrease in erectile (Stunted)”, “Swelling of veins and not strengthens”, “No development of nerves”, “Happening of Premature Ejaculation and wet dreams”, “Less or thin Semen”, “Votil – Herbal and Natural Extract Syrup”, “Long Life Results Ordinary person can also use it and can make his body healthy and his married life happier” The visuals in the Ad and packaging read in conjunction with the claims             in the advertisement imply that the product is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Janta Clinic: The advertisement’s claims, “Avoid operation, Remove piles from roots by one injection” and “Successful treatment of fistula patients through Kshar sutra therapy” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Sanjivani Ayurved Ashram: The advertisement’s claims, “Sex problems – Keep your marital life happy. Lack of sex desire, Premature ejaculation, Reduced erectile, Low & weak sperm, Undeveloped organ, Lack of stimulation due to weakness in nerves of organ”, “Our Ayurvedic treatment helps to transform your loose, undeveloped & flat breast into beautiful & attractive and improves physical attraction” and the visual in the advertisement read in conjunction with the claim objected to implies that the product is meant for breast enhancement. Also, the visuals in the advertisement read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure. The advertisement is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Sablok Clinic: The advertisement’s claims, “Meet without hesitation for sex problems”,  “No need to hide your sex related problems, if you are doing like that your marital life can become distressful” and the visuals in the advertisement in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Shivansh Ayurveda (Shivansh Ayrveda Range of Products): The advertisement’s claims, “Adopt ayurveda to increase height” and “Solution to men & women’s height through ayurvedic medicines” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.    Sex Samadhan Clinic: The advertisement’s claims, “Sexual Diseases, why get disappointed?”, “Free Japanese Penis Increaser Tool”, “Successful treatment of weakness of penis due to childhood mistakes, undeveloped organ, weakness of nerves, small organ, sloppy organ, thinness, impotence, childlessness, premature ejaculation, nightfall & every veneral diseases” and the visuals in the advertisements read in conjunction with the claims in the advertisement imply that the treatment is meant for enhancement of sexual pleasure, and are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Jivak Ayurveda: The advertisement’s claims, “Treatment of cancer”, “Complete ayurvedic solution to breast cancer, brain cancer, throat cancer, liver cancer, gallbladder cancer, blood cancer, bone cancer etc.” and “Jivak ayurveda is ray of hope for those who are suffering from cancer. See the results yourself within 21 to 45 days after taking the treatment” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Pankajakasth uri Herbals (I) Ltd. (Pankaja Kasthuri Orthoherb): The advertisement’s claim, “Use regularly and say good bye to Arthritis” is considered to be, prima facie, in violation of the DMR Act.

     

    1.    Shree Hari Clinic: The advertisement’s claims, “Get healthy without operation! Kidney Stone, Piles, Tumor, Heart Diseases”, “Childness couples must meet!” and “Operation less treatment for male – female infertility, Irregular menstruation, polycystic ovary, weak uterus and closed tube” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    S B Ayurvedic Speciality Hospital: The advertisement’s claims, “Vajikarna Treatment: Excellent medicines available in Ayurvedam without side effects for sexual problems due to mental reasons like depression, pressure, Anxiety etc. Ayurvedic medicine are giving better results. In Ayurveda, good medicines are also available for mental problems. As told in Ayurveda, Vajikarna medicines are solving problems like sexual problems, infertility” and “Get rid of sexual problems, infertility by Ayurveda experts with proper idea through sex counselling, Ayurveda medicines” are considered to be, prima facie, in violation of the DMR Act and D&C Act.

     

    1.    S B Ayurvedic Speciality Hospital: The advertisement’s claims, “In ayurveda there are excellent medicines for sexual problems arising due to Diabetes, High Blood pressure, Neurological disorders. Vajikarna medicine are used to treat sexual problems and which in turn resolves infertility problems also. By using Ayurveda medicines four to six months, Sexual and Infertility problems can be resolved,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Homeocare International: The advertisement’s claim, “Possible Prevention to ‘ASTHAMA’ with Constitutional Homeopathy” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Homeocare International: The advertisement’s claims, “Efficient solution to ‘Spondylitis’ in Homeocare International” and “making back bone strong, there by chance of completely curing spondylitis problem without retaining this disease” are considered to be, prima facie, in violation of the D&C Act.

     

    1.    Homeocare International: The advertisement’s claims, “Our Advanced Specialty Treatments to Diabetes, Peripheral, Neuropathy, Sex Problems, Kidney Problems, Diabetic foot and Eye Problems,” are considered to be, prima facie, in violation of the DMR and the D&C Act.

     

    1.    Alfa Hospital (Alfa Wellness): The advertisement’s claims, “Solution to every serious diseases of obesity at Alfa wellness: High blood pressure, Diabetes Type, Hypothyroid, and PCOD” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Makewell Pharmaceuticals (Speed Height Capsules): The advertisement’s claims, “Even after being short, there is a difference in my growth” and “Helps in physical growth” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Jolly Pharma (Jolly Fat Go Range of Products): The product name implies cure for obesity. Hence, the advertisement is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Jagat Pharma (Isotine Ayurvedic Eye Drops): The advertisement’s claims, “Treatment of less mature Cataract without operation” and “Cure for incurable diseases like Retinitis, pigmentosa, colour blindness etc.” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Navchetana Kendra (Navchetana Kendra Products-Debisulin): The advertisement’s claims, “In Ayurveda have wonderful herbs to help to cures the diabetes without side effects. Navchetana Kendra Designed a formulation Debisulin for your diabetes problems” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.     Navchetana Kendra (Navchetana Kendra Products- Recall Capsule): The advertisement’s claims, “Recall Capsule- A completely ayurvedic and chemical free capsule, made of rare herbal extract. It not just treats mental disorder/ailments but also takes care of your mind and nerve systems its good bye to stress, overthinking, depression and negativity from your mind and want to have a healthy mental state-‘Recall Capsule’ will be helpful and useful to get rid of those problems” are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Sks Ayurveda Impex Pvt. Ltd. (SKS Height Plus): The advertisement’s claim, “With the use of this medicine you will improve your height in just 90 days of usage” and the visual in the advertisement read in conjunction with the claim objected to implies that the product is meant for increasing height. This is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Cosmo Vedant Herbal India (Vedantak Vati): The advertisement’s claims, “Sure shot medicine for arthritis” and “Get rid of arthritis,” are considered to be, prima facie, in violation of the DMR Act.

     

    1.    Reva Health & Skin: The advertisement’s claim, “How to decrease the belly fat? Treatment process – In the process of decreasing fat….body’s central part such as obesity,” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Vardhan Ayurveda Hospital: The advertisement’s claim, “Treatment with best results through proven methods – Spondylitis,” is considered to be, prima facie, in violation of the D&C Act.

     

    1.    Sanjeevani Welfare Foundation (Sanjeevani Foundation): The advertisement’s claim, “Successful treatment for, Asthma, diabetes, venereal diseases through ayurved,” is considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Khodiyar Ayurvedic: The advertisement’s claims “Cure chronic Haemorrhoids, Piles, Fistula, Fissure without operation from the roots through herbs and ayurvedic medicine with moneyback guarantee” and “100% money back guarantee for giving child to childless couple,” are considered to be, prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Testo Ultra: The advertisement’s claim, “Increase member to four to eight centimetres in two weeks” and the visual in the advertisement read in conjunction with the claim objected to imply that the product is meant for improvement in the size of sexual organ. The advertisement is considered to be prima facie, in violation of the D&C Act.

     

    1.    Perfect Point: The advertisement’s claim, “Now put your first step to get freedom from diseases like obesity, blood pressure, diabetes and heart diseases,” is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Perfect Point: The advertisement’s claim, “Reduce Belly Fat. – And get Relief from problems like Obesity, Blood Pressure, Diabetes and heart diseases,” is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Ambe Physio Hospital: The advertisement’s claim, “Successful treatment of following diseases – Cervical, Paralysis, and Arthritis,” is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Hcg Regency Oncology Healthcare Private Limited: The advertisement’s claim, “Previous accurate diagnosis is essential for successful treatment of cancer,” is misleading by implication of cancer cure. The advertisement is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Super Speciality Hospital: The advertisement’s claim, “Freedom from Obesity” and the before and after visuals in the advertisement read in conjunction with the claim objected to implies cure from obesity. This is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Mithal Cancer Center Enterprise (Meerut Cancer Hospital): The advertisement’s claim, “Treatment of cancer is possible”, is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Keya Fertility: The advertisement’s claim, “This Year over 300 of Our Patients Will Be Smiling Too. Trying to conceive? Convert hope into success”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    Akshar Surgical Hospital: The advertisement’s claims, “Benefits of Obesity Surgery: Cures, Diabetes, Get rid of Heart Diseases”, is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Saaol Heart Centre: The advertisement’s claim, “Freedom from Heart diseases without operation, without surgery, without bypass, without Angioplasty”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    R K Hospital: The advertisement’s claim, “Complete treatment for infertility”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    Bhola Hospital: The advertisement’s claim, “Freedom from stones without surgery”, is considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Vansh Clinic & Test Tube Baby center: The advertisement’s claim, “Successful treatment of childless couples through Scientific method”, is considered to be prima facie, in violation of the DMR Act.

     

    1.    Shree Laser Hair & Skin Hospital Private Limited: The advertisement’s claims, “Any Type of Complicated and non-curable diseases can be Cured- Like Leucoderma, up to Hepatitis ‘B’ and Cancer in Stage I & II”, are considered to be prima facie, in violation of the DMR Act and the D&C Act.

     

    1.    Medicover Fertility: The advertisement’s claim, “Childless couples’ dream to have a healthy baby can now be fulfilled”, is considered to be prima facie, in violation of the DMR Act.

    EDUCATION:

    The CCC found following claims in the advertisements by 21 different advertisers were not substantiated and, thus, violated ASCI Guidelines for Advertising of Educational Institutions. Hence complaints against these advertisements were UPHELD.

    1.        Patel Group of Institutions: The advertisement’s claim, “Awarded for Best infrastructure, Best Faculty, Best Results & Best Placements”, was not substantiated with details of the awards, parameters used for assessment and other similar institutes that it was compared against, references of the award received such as the year, source and category. Also the claim is misleading by exaggeration.

     

    1.        Frankfinn Aviation Services Pvt. Ltd. (Frankfinn Institute of Air Hostess Training): The advertisement’s claim, “The World’s No.1”, was not substantiated with authentic supporting proof, and is misleading by exaggeration. Also the claim, “World’s No.1 air hostess training institute”, was not substantiated with any verifiable comparative data versus other similar institutes in the same category or any third party validation or research, and is misleading by exaggeration. Further the claims, “Gold Award Winner – 2016 for ‘Best Higher Vocational Institute for Skill Development’ – Awarded ‘Best Air Hostess Training Institute Award’ every year from 2011 to 2016” and “Limca Book of Records certified Frankfinn for best cabin crew placements year after year”, were not substantiated with copy of the award certificates, details, references of the awards received such as the year, source and category.  Also, the claims are misleading by omission of disclaimers to qualify these claims.

     

    1.        Jupiter: The advertisement’s claim, “The Only Institute in Patna with Experts in Every Subject”, was not substantiated with any verifiable comparative data versus other similar institutes in the same category or any third party validation or research to prove this claim, and is misleading. Also the claim, “Get Upto 100% Scholarship”, was not substantiated with authentic supporting data such as evidence of 100% scholarships availed by any of their students. The claim is misleading by exaggeration and ambiguity regarding the total number of scholarships being offered.

     

    1.        NRI Academy (HYD) – NRI Academy: The advertisement’s claim, “Guarantee the Engineering, IIT, NIT, BITS PILANI, Medical seats”, was not substantiated with any verifiable supporting data, and is misleading by exaggeration.

     

    1.        Vision 40 Academy IIT: The advertisement’s claim, “Offer guaranteed seats for IIT-JEE and NEET”, was not substantiated with any verifiable supporting data, and is misleading by exaggeration.

    Complaints against advertisements of all educational institutes listed below mostly are UPHELD because of unsubstantiated claims that they ‘provide 100% placement/AND/OR they claim to be the No.1 in their respective fields’:

    Sona School Management, OSK IT Solutions (OSK Consultant), National Academy of Event Management & Development, Rural Research and Development Agency (Sri Annai Nursing College), Nehru College of Education and Charitable Trust (Nehru Group of Institutions), PV Media Ventures Private Limited (Roc Talent Junction), Hindustan Air Academy, NILAYA’S ICATS Institute of Commerce, An IGP Pvt. Ltd. (CA Ashish Kalra’s IGP e-learning Classes), Swapnil Patni’s Classes, IAM Business School, Mentors Eduserv, Indo German Tool Room-Gv, Excellence Knowledge City-VC, S K Educations Pvt. Ltd. and Sri Nanesh Vikas Trust Samta.

     

    FOOD & BEVERAGES:

    1.        A V Thomas & Co. Ltd. (AVT Premium Tea and AVT Premium Select Tea): The advertisement’s claim, “Strongest Tea consistently” is a superlative claim which was not substantiated with supporting comparative data versus other tea brands. Also, the claim is misleading by exaggeration and implication that other tea brands are inferior to the advertised product.

     

    1.        Apurva Organics Ltd. (Chamong Green Tea): The advertisement’s claims, “100% Organic” and “IMO certified” were not substantiated and are misleading by exaggeration. 

     

    1.        Mahesh Edible Oil Industries Ltd. (Saloni Mustard Oil): The advertisement’s claims, “Vitamin A – Helps to improve eyesight”, “Vitamin D – Helps in making bone stronger” and “Vitamin E – Helps to strengthen immunity”, were not substantiated with quantitative evidence of the presence of Vitamins A, D and E in the product.

     

    1.        Sri Family Biznet (P) Ltd. (Udupi Ruchi products): The advertisement claims, “Rava Idli: The micro nutrients in this prevents insulin loss. Reduces bad fat and regular eating of this keeps you young”, “Raagi Idli: Helps fat loss. Strengthens bones, cures kidney stones and also suggested for diabetes patients”, “Oats Idli: Reduces fat storage in the body. Reduces heart diseases. Builds immunity and reduces breast cancer in females”, were inadequately substantiated and are misleading by implication. 

     

    1.        Sri Family Biznet (P) Ltd. (Udupi Ruchi Products): The advertisement’s claims, “Ragi Dosa: Cures kidney stones. Maintains haemoglobin level in the blood, maintains weight, and maintains blood pressure”, “Rice Dosa: Good for heart”, “Rava Dosa:  Helps in building the immunity power. Good for pregnant ladies and those who are in their menstrual periods to compensate for the blood loss, Controls insulin secretion, Maintains blood pressure level” and “Multi grain dosa: Improves immunity, controls diabetes, controls oestrogen secretion in women”, were inadequately substantiated and are misleading by exaggeration.

     

    1.        Keshav Industries Pvt. Ltd. (Keshav Edible Oils Range): The advertisement’s claim, “Health Booster” is misleading by implication of enhancement of health as the advertisement also states “Use Kash and be worry-free”. Further the claim, “Keeps food ingredients fresh for long” was not substantiated with any technical data, and is misleading by implication. 

     

    1.        Heinz India Pvt. Ltd. (Complan): The advertisement’s claims, “Only Complan gives three times more (3X Zyada)”, “As every glass of Complan has 34 vital nutrients, two glass of milk protein (2X Milk Protein) because of which children grow/develop the most”, were not substantiated and are misleading by ambiguity and implication. 

     

    OTHERS:

    1.        Bharti Airtel Ltd. (Free Data for 12 months): The advertisement’s claim, “Free data for 12 months, worth Rs. 9000. Switch to Airtel 4G”, is misleading by ambiguity. It was noted that the price currently being used by Airtel for 3 GB data is Rs. 450/-.  The prevalent price of ‘free data’ under an actual offer for 12 months is much lower than the price point of Rs. 9000.  The said unlimited data packs are not entirely free but they are subject to specific tariff packs for which the customer is required to pay. Furthermore, the data pack is valid for only 28 days and the 12 re-charges of 28 days each do not add up to 12 months. 

     

    1.        Bharti Airtel Ltd. (Free Unlimited local + STD calls): In view of the cap of 1200 minutes / week as per advertiser’s fair usage policy, the claim, “Free Unlimited Local + STD calls” is misleading and contravened Chapter I.4 of the ASCI Code as well as Clause 1 of ASCI Guidelines for Disclaimers (“A disclaimer can expand or clarify a claim, make qualifications, or resolve ambiguities, to explain the claim in further details, but should not contradict the material claim made or contradict the main message conveyed by the advertiser or change the dictionary meaning of the words used in the claim as received or perceived by a consumer.”).

     

    1.        Bharti Airtel Ltd.: The advertisement’s claim, “India’s fastest network” after referring to the terms and conditions (https://www.airtel.in/fastestnetwork/download/termsandconditionsfastestnetworkookla.pdf) and noting the specific clauses, was considered to be in contravention of the ASCI Guidelines on Disclaimers, Clause I, because it renders the principal claim of the advertisement being the “Fastest Network” null and void. The specific clauses are – “…..4. Airtel has no liability whatsoever in respect of any claims or disputes and any resulting damages or losses, whether direct or indirect, relating to the customers’ use of the network. 5. Airtel makes no warranties or representations whatsoever in respect of the mobile services including as to its fitness for any particular purpose, merchantability, quality, availability, disruption or error free operation. Please note that the statements in these terms and conditions do not constitute any general representation from Airtel regarding Airtel’s services or its availability. Airtel’s network is available on an ‘as is where is available’ basis and Airtel makes no representation, guarantee or warranty regarding the availability, fitness for any specified purpose or error free operation of the network. Network availability may be affected due to various reasons including force majeure, acts of god, inclement weather, topographical/ geographic/ demographic factors, maintenance work, availability of interconnection with other networks, etc.” Furthermore, the advertisement does not state in the claim itself that the speed results pertain to only a specific period (ie. “The period taken to conduct speed test is from Q3-Q4 2016”). It was also noted that the claim by the advertiser is not specific to 4G technology whereas the advertisement has visuals with reference to 4G. The speed comparison visual also has a reference to 4G in the notification bar and shows poor signal strength for the other service provider. This representation was considered to be misleading by ambiguity and implication. Further it was concluded that the claim was not adequately substantiated and the basis of comparison has been so chosen as to bestow and artificial advantage to the advertiser. Additionally, for the claim, “Officially the fastest network” it was also considered the term “Officially” to be misleading as this test is not based on any government organization or recognized authority such as TRAI in this category and hence, exploits consumers’ lack of knowledge.

     

    1.        Jewel Souk Marketplace Limited (Sangini Diamond Jewellery): The advertisement’s claim, “India’s Most trusted Jewellery Brand”, was not substantiated with any market research data or any comparative data versus other similar brands in the same category. The claim is not qualified to mention the source and date of research and criteria for assessment for the claim made. Also, the claim is misleading by ambiguity and omission. 

     

    1.        LG Electronics India Pvt. Ltd. (LG Air Conditioner): The advertisement’s claims,   “30 percent faster cooling”, “66 percent extra energy saving compared to other AC”, were not substantiated and are misleading by exaggeration and implication that other air conditioners are inferior to the advertised product. Also the claim, “keep mosquito away”, was not substantiated with supporting evidence and is misleading by exaggeration. Further the disclaimers in the advertisement are not legible, are not in the same language as the audio of the advertisement (Hindi), and the hold duration of the disclaimers is not in compliance with the ASCI Guidelines.

     

    1.         Relaxo Footwears Ltd. (Relaxo Sparx Shoes): The advertisement’s claim “India’s most trusted brand in footwear category – Brand Trust Report 2016” was likely to be understood by consumers as a comparison about the advertiser’s product with their competitor brands. It was concluded that in the absence of survey methodology, questionnaires used, names of other similar footwear that were part of the survey and their outcome, the claim was inadequately substantiated and is misleading.

     

    1.        Jasper Infotech Pvt. Ltd. (Snapdeal – Amway Persona 100% Pure Coconut Oil): The advertisement claiming the MRP of the product Amway Persona, 100% pure 400 grams as Rs.619, and offering at the discounted price of Rs.239 (61% off), is false, distorts facts and is misleading the consumers as to actual product and discount being offered, as the actual MRP of the product 500 ml (457.5 g) being Rs.190 at which it is sold.

     

    1.        Crusaders Technologies (Crusaders Air Purifier) Pvt. Ltd.: The advertisement’s claim, “India’s No.1 Air Purifier”, was not substantiated with any verifiable comparative data versus other air purifiers in the same category or any third party validation or research to prove this claim, and is misleading by exaggeration.

     

    1.    Asian Paints Ltd. (Smart Care Solutions): The advertisement’s claim, “Warranty wala waterproofing”, is misleading by omission. The advertisement does not indicate or provide reference to criteria under which the claim holds / does not hold.
  • Most watched teams of IPL 10

    BENGALURU: The tenth edition of the T20 Indian Premier League that ended on 21 May 2017 (IPL 10 or IPL 2017) garnered much better viewership than its predecessor – IPL 2016 according to Broadcast Audience Research Council of India (BARC) data. Fifty nine of the sixty matches – 55competition (56 planned) matches, two qualifiers, 1 eliminator and one final match, were played by 8 teams over 43 days (44 planned) across 47 days with over 200 Indian and international cricketers. One match – match number 29 between Royal Challengers Bangalore and Sun Risers Hyderabad on Tuesday, 24 April 2017 was not played because of incessant rain at the venue – The M. Chinnaswamy Stadium at Bangalore.

    A larger proportion of rural viewers watched IPL 10 – 47 percent of total viewers as against 39 percent of total viewers in the case of IPL 9. The ratio of male to female viewers was almost unchanged as was the ratio of HSM markets to South markets. 41 percent of females made up the viewership of IPL10 as compared to 42 percent in IPL 9, and 73 percent of the total viewers were from the HSM market in IPL 10 as compared to 72 percent in the case of IPL 9.

    Average viewership per match in IPL 2017 at 21.19 million impressions was 24 percent more than the average 17.11 million impressions that were recorded for IPL 9. On weekends, which included Saturday’s and Sunday’s along with two Mondays’ – (17 April 2017 and 1 May 2017 or May day) and two Friday’s –(14April 2017 and 28 April 2017) average Impressions for primetime matches or evening matches in IPL 10 increased 20.5 percent to 26.222 million as compared to 21.753 million for IPL 9. In all, 44 matches (43 played) were scheduled for evening primetime and 16 matches for afternoon during IPL 10’s extended weekends.

    Afternoon matches saw viewership increase 26.54 percent in IPL 10 to an average of 12.713 million per afternoon match from an average of 10.046 million per afternoon match during IPL 9.

    So which were the most watched teams of IPL 10?

    For IPL 10, matches 1 to 56 were the competition matches – each team played 2 matches with each of the other seven contestants – the only exception being match number 29 mentioned above. Hence each team was supposed to play 14 competition matches. The last four matches of IPL 10 (technically it should be 3, with the fourth being the finals –match 60) have been considered as Knockouts matches in this report by the author.All the Knockouts matches were played only in the evening. Two (matches 57 and 59) of the 3 matches were qualifiers, with one eliminator match (match 58) and one final – match 60.

    The qualifiers, the eliminator or Knockouts and the finals were sure to garner high viewership, and to bring the teams at par, only the matches before the Knockouts have been considered to determine which teams were the most watched team in IPL 10.

    Data for the matches 1 to 56 (except the washout match 29) indicates average viewership of 23.764 million per evening or primetime match during IPL10 for 39 payed evening matches before the Knockouts.  Of the 56 planned matchesuntil the Knockouts, 16 were afternoon matches as mentioned above. Forty-two evening matches had higher ratings than the highest ratings garnered by an afternoon match.

    Evening matches before the Knockouts

    Four teams had average viewership per match that were higher than the overall average viewership per match for all evening matches until the Knockouts. Please refer to the figure below.

    Team Mumbai or Mumbai Indians (MI) topped the list with 24.950 million average impressions per match, followed very closely behind by team Bangalore or Royal Challengers Bangalore (RCB) with 24.893 million average impressions per match. The two matches played by these two teams against each other were afternoon matches – one of which was the most viewed afternoon match.

    Trailing not too far behind RCB was team Pune (Rising Pune Supergiant or RPS) with average match impressions of 24.672 million permatch. Team Kolkata or Kolkata Knight Riders (KKR) was also close at fourth place with average 24.673 million impressions per match until the Knockouts in IPL 10. Also, trailing at fifth place was team Hyderabad or Sun Rises Hyderabad (SRH) with average impressions of 23.558 million per match. Team Punjab or Kings XI Punjab (KXIP), Team Gujarat (Gujarat Lions or GL) and Team Delhi (Delhi Daredevils or DD followed at sixth, seventh and eighth places respectively.

    public://11111111111_0.jpg

    The average of the sum of average weekly impressions per match – 209.778 million divided by the eight weeks or part thereof that the IPL 10 matches were played, works out to 26.222 million impressions per match. However, a simple average based on the sum of all the 43 evening IPL matches (1,043.242 million) divided by the number of matches played (43) works out to 24.261 million impressions per evening match.

    The most watched match of IPL 10 was the final with 39.403 million average impressions on Sunday, 21 May 2017. The most watched match of the season before the Knockouts was Match no 2 between Mumbai and Pune on Thursday, 6 April 2017 at Pune that had 30.328 million average impressions. It was an evening match, right at the commencement of IPL 10.

    Afternoon matches

    For the 16 afternoon matches, the simple average obtained by dividing the sum of impressions of all matches (206.733 million) by 16, works out to 12.921 million average impressions per match. Three teams scored higher viewership impressions for the afternoon sessions than the average viewership per match of all matches. Again, like in the case of evening matches, team Mumbai drew the most eyeballs with a simple average of 16.456 million impressions per match from 3 matches. The Bangalore team was next with an average of 14.228 million impressions per match from 4 afternoon matches. Team Gujarat was third with an average of 13.942 million impressions per match from 4 matches. Please refer to the figure below.

    public://22222222222222_0.jpg

    The highest rated afternoon match was Match no 12 between Bangalore and Mumbai on 14 April 2017 with 18.130 million impressions. Both teams were the most watched teams of IPL 10. The match was played on a day that was a holiday in most parts of the country.

    End Points

    Many factors could be responsible for higher viewership ratings – this could include viewer fascination for the team, more matches played by a team on a holiday/s or in the evening session/s as compared to the teams that attracted lower viewer eyeballs. Would evening matches between Mumbai and Bangalore have drawn more viewers? Both teams are composed of some of the most exciting cricketers in the world? Quite likely! It would only be a cliché to say that IPL has in general succeeded in all its seasons in affecting viewership during all of them.

    It may be noted that the average impressions per match in the afternoon mentioned in the early part of this report is based on the average of average impressions of the weeks divided by the number of weeks –this was mentioned earlier as 12.713 million per afternoon match for IPL 10 and an average of 10.046 million per afternoon match during IPL 9. However to bring parity, in the chart above, and at the cost of repetition, the average impressions per match have been obtained by adding the impressions of all the afternoon matches divided by the number of afternoon matches.